Role of T cell—glial cell interactions in creating and amplifying central nervous system inflammation and multiple sclerosis disease symptoms

Frontiers in Cellular Neuroscience

Volumn 9, Issue AUGUST, 2015, Pages

  Huseby, Eric S ^a   Kamimura, Daisuke ^b   Arima, Yasunobu ^b   Parello, Caitlin S ^a   Sasaki, Katsuhiro ^a,c   Murakami, Masaaki ^b  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c KYOTO UNIVERSITY   (Japan)

Author keywords

Astrocytes; Autoimmunity; Cerebellum; Experimental autoimmune encephalomyelitis; Glial fibrillary acidic protein; Multiple sclerosis; T cell

Indexed keywords

GAMMA INTERFERON; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 17; INTERLEUKIN 6; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; AUTOIMMUNITY; CD4+ T LYMPHOCYTE; CELL INTERACTION; CENTRAL NERVOUS SYSTEM INFECTION; GENETIC LINKAGE; GLIA CELL; HUMAN; IMMUNOREGULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MULTIPLE SCLEROSIS; NONHUMAN; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE;

EID: 84940177009     PISSN: 16625102     EISSN: None     Source Type: Journal    
DOI: 10.3389/fncel.2015.00295     Document Type: Review

References (89)

1. Anderson, A. C., Chandwaskar, R., Lee, D. H., Sullivan, J. M., Solomon, A., Rodriguez-Manzanet, R., et al. (2012). A transgenic model of central nervous system autoimmunity mediated by CD4+ and CD8+ T and B cells. J. Immunol. 188, 2084-2092. doi: 10.4049/jimmunol.1102186
2. Arima, Y., Harada, M., Kamimura, D., Park, J. H., Kawano, F., Yull, F. E., et al. (2012). Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148, 447-457. doi: 10.1016/j.cell.2012.01.022
3. Atsumi, T., Singh, R., Sabharwal, L., Bando, H., Meng, J., Arima, Y., et al. (2014). Inflammation amplifier, a new paradigm in cancer biology. Cancer Res. 74, 8-14. doi: 10.1158/0008-5472.CAN-13-2322
4. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., et al. (2000). Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192, 393-404. doi: 10.1084/jem.192.3.393
5. Ben-Nun, A., Kaushansky, N., Kawakami, N., Krishnamoorthy, G., Berer, K., Liblau, R., et al. (2014). From classic to spontaneous and humanized models of multiple sclerosis: impact on understanding pathogenesis and drug development. J. Autoimmun. 54, 33-50. doi: 10.1016/j.jaut.2014.06.004
6. Bo, L., Vedeler, C. A., Nyland, H. I., Trapp, B. D., and Mørk, S. J. (2003). Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J. Neuropathol. Exp. Neurol. 62, 723-732.
7. Booss, J., Esiri, M. M., Tourtellotte, W. W., and Mason, D. Y. (1983). Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis. J. Neurol. Sci. 62, 219-232. doi: 10.1016/0022-510x(83)90201-0
8. Calabrese, M., De Stefano, N., Atzori, M., Bernardi, V., Mattisi, I., Barachino, L., et al. (2007). Detection of cortical inflammatory lesions by double inversion recovery magnetic resonance imaging in patients with multiple sclerosis. Arch. Neurol. 64, 1416-1422. doi: 10.1001/archneur.64.10.1416
9. Chou, Y. K., Henderikx, P., Jones, R. E., Kotzin, B., Hashim, G. A., Offner, H., et al. (1992). Human CD8+ T cell clone regulates autologous CD4+ myelin basic protein specific T cells. Autoimmunity 14, 111-119. doi: 10.3109/08916939209083129
10. Correale, J., Lund, B., McMillan, M., Ko, D. Y., McCarthy, K., and Weiner, L. P. (2000). T cell vaccination in secondary progressive multiple sclerosis. J. Neuroimmunol. 107, 130-139. doi: 10.1016/s0165-5728(00)00235-6
11. Crawford, M. P., Yan, S. X., Ortega, S. B., Mehta, R. S., Hewitt, R. E., Price, D. A., et al. (2004). High prevalence of autoreactive, neuroantigen-specific CD8+ T cells in multiple sclerosis revealed by novel flow cytometric assay. Blood 103, 4222-4231. doi: 10.1182/blood-2003-11-4025
12. Cree, B. A., Rioux, J. D., McCauley, J. L., Gourraud, P. A., Goyette, P., McElroy, J., et al. (2010). A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01. PLoS One 5:e11296. doi: 10.1371/journal.pone.0011296
13. De Keyser, J., Laureys, G., Demol, F., Wilczak, N., Mostert, J., and Clinckers, R. (2010). Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis. Neurochem. Int. 57, 446-450. doi: 10.1016/j.neuint.2010.02.012
14. Dressel, A., Chin, J. L., Sette, A., Gausling, R., Höllsberg, P., and Hafler, D. A. (1997). Autoantigen recognition by human CD8 T cell clones: enhanced agonist response induced by altered peptide ligands. J. Immunol. 159, 4943-4951.
15. Ercolini, A. M., and Miller, S. D. (2006). Mechanisms of immunopathology in murine models of central nervous system demyelinating disease. J. Immunol. 176, 3293-3298. doi: 10.4049/jimmunol.176.6.3293
16. Fisher, E., Lee, J. C., Nakamura, K., and Rudick, R. A. (2008). Gray matter atrophy in multiple sclerosis: a longitudinal study.Ann. Neurol. 64, 255-265. doi: 10.1002/ana.21436
17. Fissolo, N., Haag, S., de Graaf, K. L., Drews, O., Stevanovic, S., Rammensee, H. G., et al. (2009). Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Mol. Cell. Proteomics 8, 2090-2101. doi: 10.1074/mcp.M900001-MCP200
18. Fogdell-Hahn, A., Ligers, A., Grønning, M., Hillert, J., and Olerup, O. (2000). Multiple sclerosis: a modifying influence of HLA class I genes in an HLA class II associated autoimmune disease. Tissue Antigens 55, 140-148. doi: 10.1034/j.1399-0039.2000.550205.x
19. Ford, M. L., and Evavold, B. D. (2005). Specificity, magnitude and kinetics of MOG-specific CD8+ T cell responses during experimental autoimmune encephalomyelitis. Eur. J. Immunol. 35, 76-85. doi: 10.1002/eji.200425660
20. Friese, M. A., Jakobsen, K. B., Friis, L., Etzensperger, R., Craner, M. J., McMahon, R. M., et al. (2008). Opposing effects of HLA class I molecules in tuning autoreactive CD8(+) T cells in multiple sclerosis. Nat. Med. 14, 1227-1235. doi: 10.1038/nm.1881
21. Frohman, E. M., Racke, M. K., and Raine, C. S. (2006). Multiple sclerosis-the plaque and its pathogenesis. N. Engl. J. Med.354, 942-955. doi: 10.1056/nejmra052130
22. Goverman, J. (2009). Autoimmune T cell responses in the central nervous system. Nat. Rev. Immunol. 9, 393-407. doi: 10.1038/nri2550
23. Hafler, D. A., Compston, A., Sawcer, S., Lander, E. S., Daly, M. J., De Jager, P. L., et al. (2007). Risk alleles for multiple sclerosis identified by a genomewide study. N. Engl. J. Med. 357, 851-862. doi: 10.1056/nejmoa073493
24. Hafler, D. A., Slavik, J. M., Anderson, D. E., O'Connor, K. C., De Jager, P., and Baecher-Allan, C. (2005). Multiple sclerosis.Immunol. Rev. 204, 208-231. doi: 10.1111/j.0105-2896.2005.00240.x
25. Harada, M., Kamimura, D., Arima, Y., Kohsaka, H., Nakatsuji, Y., Nishida, M., et al. (2015). Temporal expression of growth factors triggered by epiregulin regulates inflammation development. J. Immunol. 194, 1039-1046. doi: 10.4049/jimmunol.1400562
26. Harrington, C. J., Paez, A., Hunkapiller, T., Mannikko, V., Brabb, T., Ahearn, M., et al. (1998). Differential tolerance is induced in T cells recognizing distinct epitopes of myelin basic protein. Immunity 8, 571-580. doi: 10.1016/s1074-7613(00)80562-2
27. Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C., and Weiner, H. L. (1986). Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19, 578-587. doi: 10.1002/ana.410190610
28. Healy, B. C., Liguori, M., Tran, D., Chitnis, T., Glanz, B., Wolfish, C., et al. (2010). HLA B*44: protective effects in MS susceptibility and MRI outcome measures. Neurology 75, 634-640. doi: 10.1212/WNL.0b013e3181ed9c9c
29. Hillert, J., and Olerup, O. (1993). HLA and MS. Neurology 43, 2426-2427. doi: 10.1212/wnl.43.11.2426-a
30. Huseby, E. S., Huseby, P. G., Shah, S., Smith, R., and Stadinski, B. D. (2012). Pathogenic CD8 T cells in multiple sclerosis and its experimental models. Front. Immunol. 3:64. doi: 10.3389/fimmu.2012.00064
31. Huseby, E. S., Liggitt, D., Brabb, T., Schnabel, B., Ohlén, C., and Goverman, J. (2001a). A pathogenic role for myelin-specific CD8(+) T cells in a model for multiple sclerosis. J. Exp. Med. 194, 669-676. doi: 10.1084/jem.194.5.669
32. Huseby, E. S., Sather, B., Huseby, P. G., and Goverman, J. (2001b). Age-dependent T cell tolerance and autoimmunity to myelin basic protein. Immunity 14, 471-481. doi: 10.1016/s1074-7613(01)00127-3
33. Huseby, E. S., Ohlén, C., and Goverman, J. (1999). Cutting edge: myelin basic protein-specific cytotoxic T cell tolerance is maintained in vivo by a single dominant epitope in H-2k mice. J. Immunol. 163, 1115-1118.
34. International Multiple Sclerosis Genetics Consortium, Wellcome Trust Case Control Consortium, Sawcer, S., Hellenthal, G., Pirinen, M., Spencer, C. C., et al. (2011). Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature 476, 214-219. doi: 10.1038/nature10251
35. Jäger, A., Dardalhon, V., Sobel, R. A., Bettelli, E., and Kuchroo, V. K. (2009). Th1, Th17 and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183, 7169-7177. doi: 10.4049/jimmunol.0901906
36. Jiang, H., and Chess, L. (2006). Regulation of immune responses by T cells. N. Engl. J. Med. 354, 1166-1176. doi: 10.1056/nejmra055446
37. Jiang, H., Zhang, S. I., and Pernis, B. (1992). Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science256, 1213-1215. doi: 10.1126/science.256.5060.1213
38. Kamimura, D., Yamada, M., Harada, M., Sabharwal, L., Meng, J., Bando, H., et al. (2013). The gateway theory: bridging neural and immune interactions in the CNS. Front. Neurosci. 7:204. doi: 10.3389/fnins.2013.00204
39. Kawakami, N., Lassmann, S., Li, Z., Odoardi, F., Ritter, T., Ziemssen, T., et al. (2004). The activation status of neuroantigen-specific T cells in the target organ determines the clinical outcome of autoimmune encephalomyelitis. J. Exp. Med. 199, 185-197. doi: 10.1084/jem.20031064
40. Keegan, B. M., and Noseworthy, J. H. (2002). Multiple sclerosis. Annu. Rev. Med. 53, 285-302. doi: 10.1146/annurev.med.53.082901.103909
41. Killestein, J., Eikelenboom, M. J., Izeboud, T., Kalkers, N. F., Adèr, H. J., Barkhof, F., et al. (2003). Cytokine producing CD8+ T cells are correlated to MRI features of tissue destruction in MS. J. Neuroimmunol. 142, 141-148. doi: 10.1016/s0165-5728(03)00265-0
42. Kim, H. J., and Cantor, H. (2011). Regulation of self-tolerance by Qa-1-restricted CD8(+) regulatory T cells. Semin. Immunol.23, 446-452. doi: 10.1016/j.smim.2011.06.001
43. Klein, L., Klugmann, M., Nave, K. A., Tuohy, V. K., and Kyewski, B. (2000). Shaping of the autoreactive T-cell repertoire by a splice variant of self protein expressed in thymic epithelial cells. Nat. Med. 6, 56-61. doi: 10.1038/71540
44. Koh, D. R., Fung-Leung, W. P., Ho, A., Gray, D., Acha-Orbea, H., and Mak, T. W. (1992). Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256, 1210-1213. doi: 10.1126/science.256.5060.1210
45. Kojima, K., Berger, T., Lassmann, H., Hinze-Selch, D., Zhang, Y., Gehrmann, J., et al. (1994). Experimental autoimmune panencephalitis and uveoretinitis transferred to the Lewis rat by T lymphocytes specific for the S100 beta molecule, a calcium binding protein of astroglia. J. Exp. Med. 180, 817-829. doi: 10.1084/jem.180.3.817
46. Kojima, K., Wekerle, H., Lassmann, H., Berger, T., and Linington, C. (1997). Induction of experimental autoimmune encephalomyelitis by CD4+ T cells specific for an astrocyte protein, S100 beta. J. Neural Transm. Suppl. 49, 43-51. doi: 10.1007/978-3-7091-6844-8_5
47. Korn, T., Bettelli, E., Oukka, M., and Kuchroo, V. K. (2009). IL-17 and Th17 Cells. Annu. Rev. Immunol. 27, 485-517. doi: 10.1146/annurev.immunol.021908.132710
48. Kuchroo, V. K., Anderson, A. C., Waldner, H., Munder, M., Bettelli, E., and Nicholson, L. B. (2002). T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning and regulating the autopathogenic T cell repertoire. Annu. Rev. Immunol. 20, 101-123. doi: 10.1146/annurev.immunol.20.081701.141316
49. Lassmann, H., Brück, W., and Lucchinetti, C. F. (2007). The immunopathology of multiple sclerosis: an overview. Brain Pathol. 17, 210-218. doi: 10.1111/j.1750-3639.2007.00064.x
50. Lee, J., Nakagiri, T., Oto, T., Harada, M., Morii, E., Shintani, Y., et al. (2012). IL-6 amplifier, NF-κB-triggered positive feedback for IL-6 signaling, in grafts is involved in allogeneic rejection responses. J. Immunol. 189, 1928-1936. doi: 10.4049/jimmunol.1103613
51. Lindsey, J. W., Hodgkinson, S., Mehta, R., Mitchell, D., Enzmann, D., and Steinman, L. (1994). Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis. Ann. Neurol. 36, 183-189. doi: 10.1002/ana.410360210
52. Linker, R. A., Brechlin, P., Jesse, S., Steinacker, P., Lee, D. H., Asif, A. R., et al. (2009). Proteome profiling in murine models of multiple sclerosis: identification of stage specific markers and culprits for tissue damage. PLoS One 4:e7624. doi: 10.1371/journal.pone.0007624
53. Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D., and Wraith, D. C. (1995). Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3, 407-415. doi: 10.1016/1074-7613(95)90170-1
54. Lucchinetti, C., Brüuck, W., Parisi, J., Scheithauer, B., Rodriguez, M., and Lassmann, H. (2000). Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann. Neurol. 47, 707-717. doi: 10.1002/1531-8249(200006)47:6<707::aid-ana3>3.0.co;2-q
55. Lucchinetti, C. F., Popescu, B. F., Bunyan, R. F., Moll, N. M., Roemer, S. F., Lassmann, H., et al. (2011). Inflammatory cortical demyelination in early multiple sclerosis. N. Engl. J. Med. 365, 2188-2197. doi: 10.1056/NEJMoa1100648
56. McFarland, H. F., and Martin, R. (2007). Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919. doi: 10.1038/ni1507
57. Medana, I., Martinic, M. A., Wekerle, H., and Neumann, H. (2001). Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes. Am. J. Pathol. 159, 809-815. doi: 10.1016/s0002-9440(10)61755-5
58. Middeldorp, J., and Hol, E. M. (2011). GFAP in health and disease. Prog. Neurobiol. 93, 421-443. doi: 10.1016/j.pneurobio.2011.01.005
59. Murakami, M., Harada, M., Kamimura, D., Ogura, H., Okuyama, Y., Kumai, N., et al. (2013). Disease-association analysis of an inflammation-related feedback loop. Cell Rep. 3, 946-959. doi: 10.1016/j.celrep.2013.01.028
60. Nait-Oumesmar, B., Picard-Riera, N., Kerninon, C., Decker, L., Seilhean, D., Höglinger, G. U., et al. (2007). Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc. Natl. Acad. Sci. U S A 104, 4694-4699. doi: 10.1073/pnas.0606835104
61. Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., and Weinshenker, B. G. (2000). Multiple sclerosis. N. Engl. J. Med. 343, 938-952. doi: 10.1056/NEJM200009283431307
62. Odoardi, F., Sie, C., Streyl, K., Ulaganathan, V. K., Schläger, C., Lodygin, D., et al. (2012). T cells become licensed in the lung to enter the central nervous system. Nature 488, 675-679. doi: 10.1038/nature11337
63. Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M., et al. (2008). Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29, 628-636. doi: 10.1016/j.immuni.2008.07.018
64. Ontaneda, D., Hyland, M., and Cohen, J. A. (2012). Multiple sclerosis: new insights in pathogenesis and novel therapeutics.Annu. Rev. Med. 63, 389-404. doi: 10.1146/annurev-med-042910-135833
65. Ortega, S. B., Kashi, V. P., Tyler, A. F., Cunnusamy, K., Mendoza, J. P., and Karandikar, N. J. (2013). The disease-ameliorating function of autoregulatory CD8 T cells is mediated by targeting of encephalitogenic CD4 T cells in experimental autoimmune encephalomyelitis. J. Immunol. 191, 117-126. doi: 10.4049/jimmunol.1300452
66. Patsopoulos, N. A., Esposito, F., Reischl, J., Lehr, S., Bauer, D., Heubach, J., et al. (2011). Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 70, 897-912. doi: 10.1002/ana.22609
67. Peterson, J. W., Bö, L., Mörk, S., Chang, A., and Trapp, B. D. (2001). Transected neurites, apoptotic neurons and reduced inflammation in cortical multiple sclerosis lesions. Ann. Neurol. 50, 389-400. doi: 10.1002/ana.1123
68. Pierson, E., Simmons, S. B., Castelli, L., and Goverman, J. M. (2012). Mechanisms regulating regional localization of inflammation during CNS autoimmunity. Immunol. Rev. 248, 205-215. doi: 10.1111/j.1600-065x.2012.01126.x
69. Ransohoff, R. M., and Estes, M. L. (1991). Astrocyte expression of major histocompatibility complex gene products in multiple sclerosis brain tissue obtained by stereotactic biopsy. Arch. Neurol. 48, 1244-1246. doi: 10.1001/archneur.1991.00530240048017
70. Rice, G. P., Hartung, H. P., and Calabresi, P. A. (2005). Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology 64, 1336-1342. doi: 10.1212/01.wnl.0000158329.30470.d0
71. Sabharwal, L., Kamimura, D., Meng, J., Bando, H., Ogura, H., Nakayama, C., et al. (2014). The gateway reflex, which is mediated by the inflammation amplifier, directs pathogenic immune cells into the CNS. J. Biochem. 156, 299-304. doi: 10.1093/jb/mvu057
72. Sasaki, K., Bean, A., Shah, S., Schutten, E., Huseby, P. G., Peters, B., et al. (2014). Relapsing-remitting central nervous system autoimmunity mediated by GFAP-specific CD8 T cells. J. Immunol. 192, 3029-3042. doi: 10.4049/jimmunol.1302911
73. Schenkel, J. M., and Masopust, D. (2014). Tissue-resident memory T cells. Immunity 41, 886-897. doi: 10.1016/j.immuni.2014.12.007
74. Schmidt, S., Linington, C., Zipp, F., Sotgiu, S., de Waal Malefyt, R., Wekerle, H., et al. (1997). Multiple sclerosis: comparison of the human T-cell response to S100 beta and myelin basic protein reveals parallels to rat experimental autoimmune panencephalitis. Brain 120(Pt. 8), 1437-1445. doi: 10.1093/brain/120.8.1437
75. Schwab, N., Bien, C. G., Waschbisch, A., Becker, A., Vince, G. H., Dornmair, K., et al. (2009). CD8+ T-cell clones dominate brain infiltrates in Rasmussen encephalitis and persist in the periphery. Brain 132, 1236-1246. doi: 10.1093/brain/awp003
76. Sospedra, M., and Martin, R. (2005). Immunology of multiple sclerosis. Annu. Rev. Immunol. 23, 683-747. doi: 10.1146/annurev.immunol.23.021704.115707
77. Standifer, N. E., Ouyang, Q., Panagiotopoulos, C., Verchere, C. B., Tan, R., Greenbaum, C. J., et al. (2006). Identification of Novel HLA-A*0201-restricted epitopes in recent-onset type 1 diabetic subjects and antibody-positive relatives. Diabetes 55, 3061-3067. doi: 10.3410/f.1047982.498017
78. Steinman, L. (2009). A molecular trio in relapse and remission in multiple sclerosis. Nat. Rev. Immunol. 9, 440-447. doi: 10.1038/nri2548
79. Stromnes, I. M., and Goverman, J. M. (2006). Active induction of experimental allergic encephalomyelitis. Nat. Protoc. 1, 1810-1819. doi: 10.1038/nprot.2006.285
80. Sun, D., Whitaker, J. N., Huang, Z., Liu, D., Coleclough, C., Wekerle, H., et al. (2001). Myelin antigen-specific CD8+ T cells are encephalitogenic and produce severe disease in C57BL/6 mice. J. Immunol. 166, 7579-7587. doi: 10.4049/jimmunol.166.12.7579
81. Targoni, O. S., and Lehmann, P. V. (1998). Endogenous myelin basic protein inactivates the high avidity T cell repertoire. J. Exp. Med. 187, 2055-2063. doi: 10.1084/jem.187.12.2055
82. Traugott, U., Reinherz, E. L., and Raine, C. S. (1983). Multiple sclerosis. Distribution of T cells, T cell subsets and Ia-positive macrophages in lesions of different ages. J. Neuroimmunol. 4, 201-221. doi: 10.1016/0165-5728(83)90036-x
83. Tsuchida, T., Parker, K. C., Turner, R. V., McFarland, H. F., Coligan, J. E., and Biddison, W. E. (1994). Autoreactive CD8+ T-cell responses to human myelin protein-derived peptides. Proc. Natl. Acad. Sci. U S A 91, 10859-10863. doi: 10.1073/pnas.91.23.10859
84. van Oosten, B. W., Barkhof, F., Truyen, L., Boringa, J. B., Bertelsmann, F. W., von Blomberg, B. M., et al. (1996). Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 47, 1531-1534. doi: 10.1212/wnl.47.6.1531
85. Wong, G. H., Bartlett, P. F., Clark-Lewis, I., Battye, F., and Schrader, J. W. (1984). Inducible expression of H-2 and Ia antigens on brain cells. Nature 310, 688-691. doi: 10.1016/s0163-4453(85)91430-6
86. Zang, Y. C., Li, S., Rivera, V. M., Hong, J., Robinson, R. R., Breitbach, W. T., et al. (2004). Increased CD8+ cytotoxic T cell responses to myelin basic protein in multiple sclerosis. J. Immunol. 172, 5120-5127. doi: 10.4049/jimmunol.172.8.5120
87. Zelenika, D., Grima, B., Brenner, M., and Pessac, B. (1995). A novel glial fibrillary acidic protein mRNA lacking exon 1. Brain Res. Mol. Brain Res. 30, 251-258. doi: 10.1016/0169-328x(95)00010-p
88. Zhang, J., Medaer, R., Stinissen, P., Hafler, D., and Raus, J. (1993). MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination. Science 261, 1451-1454. doi: 10.1126/science.7690157
89. Zimmer, D. B., Cornwall, E. H., Landar, A., and Song, W. (1995). The S100 protein family: history, function and expression.Brain Res. Bull. 37, 417-429. doi: 10.1016/0361-9230(95)00040-2